Literature DB >> 24573885

Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro.

Puhui Zhou1, Tielin Chen, Yin Fang, Honglian Wang, Mi Li, Pengpeng Ma, Lu He, Qianyin Li, Tianming Liu, Xianggui Yang, Fang Nie, Xiaoyan Wang, Yue Yuan, Li Zhou, Rui Peng, Zhicheng Liu, Qin Zhou.   

Abstract

Embryonic Six2-positive nephron progenitor cells adjacent to ureteric bud tips ultimately give rise to nephron structures, including proximal and distal tubules, podocytes, Bowman's capsules, and the glomeruli. This process requires an internal balance between self-renew and differentiation of the nephron progenitor cells, which is mediated by numerous molecules. Recent studies have shown that the neurofibromin (Nf1) null mutant mouse embryos have an 18- to 24-h developmental delay in metanephros manifesting retardation in its cephalad repositioning and reduction number of glomeruli. However, the underlying inter-/intracellular signaling mechanisms responsible for reducing number of glomeruli during nephrogenesis remain to be fully elucidated. Here, we originally detected the Nf1 expression in developing kidney and metanephric mesenchyme cells. Surprisingly, Nf1 knockdown by small interfering RNAs in the metanephric mesenchyme cells (mK3) resulted in a decreased expression of Six2, the key marker of renal progenitor cells, while the ratio of apoptotic cells was significantly increased. Furthermore, overexpression of Six2 in mk3 cells partially rescued apoptosis phenotype. Collectively, these results implied that knockdown of Nf1 resulted in apoptosis of mK3 cells in vitro probably through down-regulation of Six2 expression. Collectively, we demonstrated that down-regulated Six2 by knockdown of Nf1 resulted in apoptosis of mK3 cells in vitro. These results implied that inhibition of Nf1 may delay metanephros development via down-regulation of Six2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24573885     DOI: 10.1007/s11010-014-1971-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Neurofibromatosis 1. Introduction.

Authors:  D Viskochil
Journal:  Am J Med Genet       Date:  1999-03-26

2.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2.

Authors:  M Venturin; P Guarnieri; F Natacci; M Stabile; R Tenconi; M Clementi; C Hernandez; P Thompson; M Upadhyaya; L Larizza; P Riva
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

Review 3.  Focal segmental glomerular sclerosis in a patient with neurofibromatosis type I.

Authors:  Michael S Gersch; Zvi Talor
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

4.  Neurofibromatosis type 1 is a genetic skeletal disorder.

Authors:  David A Stevenson; David H Viskochil; John C Carey
Journal:  Am J Med Genet A       Date:  2007-09-01       Impact factor: 2.802

5.  Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

Authors:  A E Lin; P H Birch; B R Korf; R Tenconi; M Niimura; M Poyhonen; K Armfield Uhas; M Sigorini; R Virdis; C Romano; E Bonioli; P Wolkenstein; E K Pivnick; M Lawrence; J M Friedman
Journal:  Am J Med Genet       Date:  2000-11-13

6.  Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.

Authors:  Andrew S McDaniel; Jayme D Allen; Su-Jung Park; Zahara M Jaffer; Elizabeth G Michels; Sarah J Burgin; Shi Chen; Waylan K Bessler; Clemens Hofmann; David A Ingram; Jonathan Chernoff; D Wade Clapp
Journal:  Blood       Date:  2008-09-02       Impact factor: 22.113

7.  Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia.

Authors:  Scott Boyle; Andrew Misfeldt; Kelly J Chandler; Karen K Deal; E Michelle Southard-Smith; Douglas P Mortlock; H Scott Baldwin; Mark de Caestecker
Journal:  Dev Biol       Date:  2007-10-24       Impact factor: 3.582

8.  Identification and characterization of the neurofibromatosis type 1 protein product.

Authors:  J E DeClue; B D Cohen; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

10.  Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways.

Authors:  Farsad Afshinnia; Virginia Vega-Warner; Paul Killen
Journal:  Clin Kidney J       Date:  2013-04
View more
  7 in total

1.  Six2 is involved in GATA1-mediated cell apoptosis in mouse embryonic kidney-derived cell lines.

Authors:  Hua Xia; Xin Yan; Yamin Liu; Pan Ju; Jianing Liu; Dongsheng Ni; Yuping Gu; Qin Zhou; Yajun Xie
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-08-25       Impact factor: 2.416

2.  Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.

Authors:  Dongjian Song; Lifang Yue; Gang Wu; Shanshan Ma; Lihua Guo; Heying Yang; Qiuliang Liu; Da Zhang; Ziqiang Xia; Lei Wang; Junjie Zhang; Wei Zhao; Fei Guo; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2015-04-29

Review 3.  Developmental Genetics and Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Natalie Uy; Kimberly Reidy
Journal:  J Pediatr Genet       Date:  2015-09-07

4.  Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.

Authors:  Huaying Hou; Xiaoming Yu; Ping Cong; Yong Zhou; Ying Xu; Yuhua Jiang
Journal:  Cell Prolif       Date:  2019-04-22       Impact factor: 6.831

5.  Zeb1 Is a Potential Regulator of Six2 in the Proliferation, Apoptosis and Migration of Metanephric Mesenchyme Cells.

Authors:  Yuping Gu; Ya Zhao; Yuru Zhou; Yajun Xie; Pan Ju; Yaoshui Long; Jianing Liu; Dongsheng Ni; Fen Cao; Zhongshi Lyu; Zhaomin Mao; Jin Hao; Yiman Li; Qianya Wan; Quist Kanyomse; Yamin Liu; Die Ren; Yating Ning; Xiaofeng Li; Qin Zhou; Bing Li
Journal:  Int J Mol Sci       Date:  2016-08-06       Impact factor: 5.923

6.  Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression.

Authors:  J Gao; X-Y Kang; S Sun; L Li; B-L Zhang; Y-Q Li; D-S Gao
Journal:  Cell Death Dis       Date:  2016-05-05       Impact factor: 8.469

Review 7.  Concepts for a therapeutic prolongation of nephrogenesis in preterm and low-birth-weight babies must correspond to structural-functional properties in the nephrogenic zone.

Authors:  Will W Minuth
Journal:  Mol Cell Pediatr       Date:  2017-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.